It's late morning and steam is rising from water tanks atop the colorful but opaque-windowed "soapland" sex parlors in a ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.